You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
本港第一劑新冠疫苗接種逾281.7萬劑
阿思達克 07-19 09:31
港府公佈,2019冠狀病毒病疫苗接種計劃自2月26日正式展開,昨日(18日)已是第143日。接種計劃開展以來,政府已爲參與計劃的人士接種共482.68萬劑疫苗,其中第一劑疫苗接種總數爲281.71萬劑,第二劑疫苗接種總數爲200.97萬劑。科興疫苗第一劑接種人數爲114.36萬,第二劑爲82.83萬;復必泰疫苗第一劑接種人數爲167.35萬,第二劑爲118.14萬。

截至昨日下午8時的過去24小時,共有約5.53萬人接種了疫苗,和約3.53萬人預約了接種時間。其中,5,700人接種第一劑科興疫苗,2.1萬人接種第一劑復必泰疫苗。

截至昨日零時零分,過去24小時共有10宗由社區疫苗接種中心送院的個案,他們因接種後出現常見副作用而送院,情況穩定,其中八人已經出院,一人留院觀察,一人不遵從醫生勸告自行出院。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account